New tumor organoids strengthen precision oncology research
Significant advances have been made in the development of patient-derived tumor “organoids” for preclinical research, in two new studies led by Weill Cornell Medicine investigators.
Significant advances have been made in the development of patient-derived tumor “organoids” for preclinical research, in two new studies led by Weill Cornell Medicine investigators.